Product image of Kyleena (Levonorgestrel) supplied by GNH India

Kyleena

Active Ingredient:
Levonorgestrel
Origin:
EU

Kyleena (Levonorgestrel)

Levonorgestrel, the active ingredient in Kyleena, is a progestin presented as a 19.5 mg intrauterine system (IUS) for intrauterine use. Delivered directly to the uterine cavity, it releases hormone continuously to provide long‑acting reversible contraception for women of reproductive age.

GNH India supplies Kyleena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality compliance with EU standards and provides global logistics support.

Manufacturer / TM Owner

Bayer D.O.O

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kyleena, a levonorgestrel‑based intrauterine system, is indicated for hormonal contraception.

  • Contraception: Prevents pregnancy for up to five years with a single insertion.
  • Hormonal birth control: Provides continuous progestin release to suppress ovulation in many cycles.
  • Menstrual management: May reduce menstrual blood loss and lessen dysmenorrhea in some users.

How It Works

  • Levonorgestrel released from the intrauterine system binds to progesterone receptors in the cervical mucus, endometrium and ovary. This action thickens cervical mucus, inhibits endometrial proliferation, and suppresses the hypothalamic‑pituitary‑ovarian axis, preventing ovulation in a proportion of cycles. The localized delivery maintains effective hormone levels within the uterus while minimizing systemic exposure.

Side Effects

Side effects associated with Kyleena vary in frequency and severity.

Common Side Effects

  • Irregular bleeding or spotting
  • Amenorrhea (absence of periods)
  • Pelvic or cramping pain after insertion
  • Headache
  • Breast tenderness

Serious or Rare Side Effects

  • Uterine perforation
  • Expulsion of the device
  • Pelvic infection (e.g., PID)
  • Ectopic pregnancy if contraception fails

Precautions & Warnings

Key precautions should be observed before and after Kyleena insertion.

  • Pregnancy testing: Confirm the patient is not pregnant prior to insertion.
  • Uterine abnormalities: Contraindicated in known uterine malformations or fibroids that distort the cavity.
  • Active infection: Do not insert in the presence of pelvic inflammatory disease or untreated sexually transmitted infection.
  • Breastfeeding: Use with caution during the early postpartum period, especially within six weeks after delivery.
  • Smoking: Advise women over 35 who smoke to consider alternative contraception.
  • Store at ambient temperature: Keep the device in its original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Levonorgestrel efficacy can be altered by concomitant medications.

Major Interactions (Avoid)

  • Enzyme inducers (e.g., rifampin, carbamazepine) may reduce levonorgestrel levels and decrease contraceptive effectiveness.
  • Antiepileptic drugs (e.g., phenytoin, phenobarbital) can similarly lower hormone concentrations.

Moderate Interactions (Monitor Closely)

  • Antifungal azoles (e.g., ketoconazole) may increase levonorgestrel exposure, requiring monitoring for hormonal side effects.
  • Certain antibiotics (e.g., tetracycline, metronidazole) have limited evidence of interaction but should be observed.
  • Herbal supplements such as St. John’s wort may induce metabolism and reduce efficacy.

Frequently Asked Questions

Kyleena is a levonorgestrel‑containing intrauterine system that provides long‑acting reversible contraception. It is inserted into the uterus and can prevent pregnancy for up to five years, offering a highly effective hormonal birth‑control option for women of reproductive age.

Levonorgestrel released from the device binds to progesterone receptors, thickening cervical mucus, inhibiting endometrial growth, and suppressing ovulation in many cycles. These combined actions create an environment that prevents fertilisation and implantation.

Kyleena is supplied as a single intrauterine system containing 19.5 mg of levonorgestrel. The prescribing clinician determines the need for insertion, and the device is designed to remain effective for up to five years without further dosing.

Kyleena is contraindicated in pregnancy (Category X) and must be removed if pregnancy occurs. While it can be used during breastfeeding, especially after the early postpartum period, clinicians usually assess individual risk and advise accordingly.

To request Kyleena, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with copper IUDs, Kyleena releases a progestin hormone, which can reduce menstrual bleeding and avoid copper‑related side effects. Compared with larger hormonal IUDs such as Mirena, Kyleena is smaller and contains a lower hormone dose, making it suitable for women with a smaller uterine cavity.

Kyleena should be stored at ambient temperature, preferably below 25 °C. Keep the device in its original sterile packaging, protect it from moisture and direct sunlight, and handle it only in a clean clinical environment until insertion.

Kyleena is inserted by a trained healthcare professional during a brief office procedure. The device is placed through the cervical canal into the uterine cavity using a specialized inserter, after which the insertion tube is removed and the IUS remains in place.

Serious risks include uterine perforation during insertion, expulsion of the device, pelvic infection such as PID, and the rare possibility of ectopic pregnancy if contraceptive failure occurs. Patients should be monitored for these complications and seek medical attention if symptoms arise.

Kyleena is contraindicated in women who are pregnant, have active pelvic infection, known uterine anomalies or fibroids that distort the cavity, have unexplained vaginal bleeding, or are allergic to levonorgestrel. Women with certain cancers or severe liver disease should also avoid its use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levonorgestrel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT